AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
Log in

NYSE:TEVATeva Pharmaceutical Industries SEC Filings & 10K Form

$11.52
+0.17 (+1.50 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.37
Now: $11.52
$11.77
50-Day Range
$10.97
MA: $12.21
$13.12
52-Week Range
$6.07
Now: $11.52
$13.76
Volume6.87 million shs
Average Volume17.12 million shs
Market Capitalization$12.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.65

SEC Filings

Teva Pharmaceutical Industries (NYSE:TEVA) SEC Filings

DateFilerForm TypeView
06/15/2020
6:37 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:36 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:35 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:35 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:34 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:33 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:32 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:31 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:31 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:18 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:17 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2020
6:16 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:15 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:14 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:13 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:13 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:12 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:11 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:10 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
6:09 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
7:28 AM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
05/07/2020
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
6:57 AM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
04/22/2020
6:54 AM
Teva Pharmaceutical Industries (Filer)
Form DEF 14A
03/19/2020
3:19 PM
Teva Pharmaceutical Industries (Filer)
Form PRE 14A
03/19/2020
7:09 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:38 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:37 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:36 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:33 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:32 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:31 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
7:16 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
7:13 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
7:11 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
7:10 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
7:07 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
5:39 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:21 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:19 AM
Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:18 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:17 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:16 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:14 AM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:12 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:11 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:10 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:08 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:06 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
8:59 AM
Teva Pharmaceutical Industries (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2020
6:17 PM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:26 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:25 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:23 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:22 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:21 AM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:19 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:08 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:06 AM
Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:05 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:04 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:03 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
6:07 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2020
6:06 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:04 AM
Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:03 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:02 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:01 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
5:57 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
5:56 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
5:53 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
5:52 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
5:08 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
5:05 AM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2019
5:32 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
3:04 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:05 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
5:46 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
6:19 AM
Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
4:11 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
5:42 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2019
7:15 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
6:19 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:19 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:17 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:12 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:11 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:10 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
5:58 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
6:05 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
5:28 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:26 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:26 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:18 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:17 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:16 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:11 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:08 AM
GOLDBERG MURRAY A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.